Myriad Genetics - 29 Year Stock Price History | MYGN

Historical daily share price chart and data for Myriad Genetics since 1995 adjusted for splits and dividends. The latest closing stock price for Myriad Genetics as of November 27, 2024 is 16.28.
  • The all-time high Myriad Genetics stock closing price was 61.23 on November 06, 2000.
  • The Myriad Genetics 52-week high stock price is 29.30, which is 80% above the current share price.
  • The Myriad Genetics 52-week low stock price is 14.72, which is 9.6% below the current share price.
  • The average Myriad Genetics stock price for the last 52 weeks is 22.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Myriad Genetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 22.9858 19.0000 28.6000 15.0000 16.2800 -14.94%
2023 19.6036 15.2600 23.7600 13.9100 19.1400 31.91%
2022 21.9787 28.0100 28.0100 14.5100 14.5100 -47.43%
2021 29.8842 19.9200 36.6600 19.9200 27.6000 39.57%
2020 15.9993 27.3500 29.5300 9.7800 19.7750 -27.38%
2019 28.8167 29.0000 47.0800 20.9300 27.2300 -6.33%
2018 37.0251 34.9100 50.3400 27.2300 29.0700 -15.36%
2017 25.3318 16.9300 37.1400 15.4000 34.3450 106.03%
2016 28.9086 42.8300 42.8300 16.2600 16.6700 -61.38%
2015 36.9074 34.6100 46.1600 30.9400 43.1600 26.72%
2014 35.2888 21.7200 42.2100 21.0300 34.0600 62.35%
2013 27.1721 27.6800 34.2600 20.7900 20.9800 -23.01%
2012 25.3547 21.0000 30.6500 20.3600 27.2500 30.13%
2011 20.8191 22.2300 25.5300 17.8600 20.9400 -8.32%
2010 19.8918 26.6600 26.9200 14.4900 22.8400 -12.46%
2009 31.4194 32.5829 43.8378 22.8500 26.0900 -17.37%
2008 25.1092 21.9856 33.8456 16.5726 31.5727 42.74%
2007 19.6255 14.9382 28.0323 14.8810 22.1190 48.31%
2006 12.2075 10.3019 15.0335 10.0446 14.9144 50.48%
2005 9.2405 10.5401 12.3318 7.2428 9.9111 -7.60%
2004 7.9792 6.4708 11.3931 5.8085 10.7260 75.04%
2003 6.1285 7.1522 8.5388 4.0979 6.1278 -11.92%
2002 11.7849 24.0107 24.0107 6.3612 6.9569 -72.26%
2001 24.3898 33.1166 36.8094 12.3556 25.0828 -36.39%
2000 31.2656 10.8999 61.2299 9.8873 39.4302 259.78%
1999 3.4556 2.5326 11.1977 2.0549 10.9594 360.00%
1998 3.7612 5.7775 6.0158 1.7869 2.3825 -58.76%
1997 6.6744 5.7775 10.8117 5.1819 5.7775 -3.96%
1996 6.1546 7.0283 8.3983 4.1098 6.0158 -22.62%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.481B $0.753B
Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made significant progress in transition & expand the hereditary cancer market, diversify revenues by commercializing its new products, increase the company's international contribution by investing in large countries, gaining reimbursement for new products, increasing international RNA kit revenue and enhancing profitability. Its flagship product BRACAnalysis offers a comprehensive analysis of BRCA1 and BRCA2 genes to assess a woman's risk of hereditary breast and ovarian cancers. Its major products are myRisk Hereditary Cancer, myPlan Lung Cancer and molecular diagnostic test myPath Melanoma. It acquired Counsyl, Inc. The company has 2 operating units: Molecular diagnostic & Pharmaceutical and clinical services.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $152.052B 14.72
Vertex Pharmaceuticals (VRTX) United States $120.557B 0.00
Bristol Myers Squibb (BMY) United States $120.109B 50.62
Gilead Sciences (GILD) United States $115.379B 20.90
CSL (CSLLY) Australia $88.978B 0.00
Regeneron Pharmaceuticals (REGN) United States $82.441B 18.76
GSK (GSK) United Kingdom $70.736B 8.18
Argenex SE (ARGX) Netherlands $37.220B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.641B 0.00
BioNTech SE (BNTX) Germany $28.383B 0.00
Biogen (BIIB) United States $23.407B 10.05
Illumina (ILMN) United States $22.862B 83.32
BeiGene (BGNE) Cayman Islands $20.940B 0.00
Moderna (MRNA) United States $16.570B 0.00
Incyte (INCY) United States $14.370B 0.00
Genmab (GMAB) Denmark $14.228B 20.87
Insmed (INSM) United States $13.446B 0.00
Sarepta Therapeutics (SRPT) United States $12.737B 114.95
BioMarin Pharmaceutical (BMRN) United States $12.584B 29.22
Bio-Techne Corp (TECH) United States $11.974B 46.23
Vaxcyte (PCVX) United States $11.758B 0.00
Exact Sciences (EXAS) United States $11.490B 0.00
Exelixis (EXEL) United States $10.412B 23.67
QIAGEN (QGEN) Netherlands $9.911B 20.39
Revolution Medicines (RVMD) United States $9.731B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.407B 31.97
Roivant Sciences (ROIV) United Kingdom $9.252B 0.00
Intra-Cellular Therapies (ITCI) United States $9.080B 0.00
Repligen (RGEN) United States $8.434B 109.88
Ascendis Pharma (ASND) Denmark $8.252B 0.00
Legend Biotech (LEGN) United States $7.718B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.351B 7.19
Nuvalent (NUVL) United States $6.869B 0.00
Halozyme Therapeutics (HALO) United States $6.132B 13.85
Blueprint Medicines (BPMC) United States $6.123B 0.00
Cytokinetics (CYTK) United States $6.120B 0.00
Viking Therapeutics (VKTX) United States $5.899B 0.00
Krystal Biotech (KRYS) United States $5.678B 94.01
Telix Pharmaceuticals (TLX) $5.520B 0.00
TG Therapeutics (TGTX) United States $5.417B 0.00
Avidity Biosciences (RNA) United States $5.134B 0.00
Arcellx (ACLX) United States $4.762B 0.00
Axsome Therapeutics (AXSM) United States $4.760B 0.00
ADMA Biologics Inc (ADMA) United States $4.754B 50.28
Alkermes (ALKS) Ireland $4.696B 15.77
Biohaven (BHVN) United States $4.653B 0.00
Guardant Health (GH) United States $4.400B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.398B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.368B 0.00
Apellis Pharmaceuticals (APLS) United States $4.221B 0.00
Immunovant (IMVT) United States $4.139B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.813B 0.00
Scholar Rock Holding (SRRK) United States $3.735B 0.00
Denali Therapeutics (DNLI) United States $3.598B 0.00
ImmunityBio (IBRX) United States $3.512B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.478B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.250B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.239B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.168B 0.00
Vera Therapeutics (VERA) United States $3.150B 0.00
Zai Lab (ZLAB) China $3.134B 0.00
Edgewise Therapeutics (EWTX) United States $3.125B 0.00
SpringWorks Therapeutics (SWTX) United States $3.086B 0.00
Merus (MRUS) Netherlands $3.070B 0.00
Kymera Therapeutics (KYMR) United States $3.034B 0.00
Amicus Therapeutics (FOLD) United States $2.982B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.955B 0.00
Twist Bioscience (TWST) United States $2.919B 0.00
Vericel (VCEL) United States $2.870B 969.00
Iovance Biotherapeutics (IOVA) United States $2.841B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.716B 20.92
Protagonist Therapeutics (PTGX) United States $2.610B 16.47
Geron (GERN) United States $2.491B 0.00
Janux Therapeutics (JANX) United States $2.373B 0.00
IDEAYA Biosciences (IDYA) United States $2.365B 0.00
CG Oncology (CGON) United States $2.350B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.342B 0.00
Keros Therapeutics (KROS) United States $2.339B 0.00
WAVE Life Sciences (WVE) Singapore $2.303B 0.00
Ligand Pharmaceuticals (LGND) United States $2.295B 57.30
NeoGenomics (NEO) United States $2.276B 0.00
Beam Therapeutics (BEAM) United States $2.266B 0.00
Akero Therapeutics (AKRO) United States $2.241B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.219B 0.00
NovoCure (NVCR) Jersey $2.168B 0.00
Bavarian Nordic (BVNRY) Denmark $2.152B 13.19
Apogee Therapeutics (APGE) United States $2.033B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.005B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.977B 16.43
Belite Bio (BLTE) United States $1.937B 0.00
Structure Therapeutics (GPCR) United States $1.898B 0.00
Fortrea Holdings (FTRE) United States $1.888B 60.14
Disc Medicine (IRON) United States $1.888B 0.00
MannKind (MNKD) United States $1.870B 48.43
Arvinas (ARVN) United States $1.836B 0.00
Galapagos (GLPG) Belgium $1.821B 0.00
Celldex Therapeutics (CLDX) United States $1.820B 0.00
Certara (CERT) United States $1.805B 50.96
Viridian Therapeutics (VRDN) United States $1.707B 0.00
Dynavax Technologies (DVAX) United States $1.691B 98.92
Immunocore Holdings (IMCR) United Kingdom $1.638B 0.00
Neumora Therapeutics (NMRA) United States $1.606B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.594B 0.00
Intellia Therapeutics (NTLA) United States $1.591B 0.00
Nurix Therapeutics (NRIX) United States $1.566B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.526B 0.00
Praxis Precision Medicines (PRAX) United States $1.494B 0.00
Travere Therapeutics (TVTX) United States $1.468B 0.00
Spyre Therapeutics (SYRE) United States $1.462B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.427B 0.00
Arcus Biosciences (RCUS) United States $1.413B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.405B 0.00
Novavax (NVAX) United States $1.397B 0.00
MiMedx (MDXG) United States $1.359B 35.58
Mesoblast (MESO) Australia $1.335B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.312B 0.00
ANI Pharmaceuticals (ANIP) United States $1.203B 16.40
Upstream Bio (UPB) United States $1.172B 0.00
Gyre Therapeutics (GYRE) United States $1.170B 0.00
Bicara Therapeutics (BCAX) United States $1.131B 0.00
Septerna (SEPN) United States $1.123B 0.00
Vir Biotechnology (VIR) United States $1.096B 0.00
Cogent Biosciences (COGT) United States $1.050B 0.00
ArriVent BioPharma (AVBP) United States $1.010B 0.00
Immatics (IMTX) Germany $0.993B 0.00
LENZ Therapeutics (LENZ) United States $0.979B 0.00
Liquidia Technologies (LQDA) United States $0.978B 0.00
Nuvation Bio (NUVB) United States $0.976B 0.00
Zymeworks (ZYME) United States $0.970B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.970B 0.00
Replimune (REPL) United States $0.963B 0.00
89BIO (ETNB) United States $0.954B 0.00
Poseida Therapeutics (PSTX) United States $0.907B 0.00
AbCellera Biologics (ABCL) Canada $0.889B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.883B 0.00
Adaptive Biotechnologies (ADPT) United States $0.877B 0.00
Prothena (PRTA) Ireland $0.872B 0.00
Kura Oncology (KURA) United States $0.859B 0.00
Castle Biosciences (CSTL) United States $0.848B 151.40
Immunome (IMNM) United States $0.846B 0.00
Cytek Biosciences (CTKB) United States $0.841B 0.00
Pliant Therapeutics (PLRX) United States $0.840B 0.00
CARGO Therapeutics (CRGX) United States $0.837B 0.00
Rapport Therapeutics (RAPP) United States $0.835B 0.00
Erasca (ERAS) United States $0.809B 0.00
Anavex Life Sciences (AVXL) United States $0.802B 0.00
Tyra Biosciences (TYRA) United States $0.793B 0.00
Avid Bioservices (CDMO) United States $0.783B 0.00
Cullinan Therapeutics (CGEM) United States $0.783B 0.00
Pacira BioSciences (PCRX) United States $0.781B 7.35
AnaptysBio (ANAB) United States $0.760B 0.00
Entrada Therapeutics (TRDA) United States $0.744B 12.51
Tectonic Therapeutic (TECX) United States $0.734B 0.00
Dianthus Therapeutics (DNTH) United States $0.710B 0.00
Oric Pharmaceuticals (ORIC) United States $0.699B 0.00
MBX Biosciences (MBX) United States $0.680B 0.00
BioAge Labs (BIOA) United States $0.674B 0.00
Arbutus Biopharma (ABUS) United States $0.656B 0.00
Oculis Holding AG (OCS) Switzerland $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.643B 5.22
Stoke Therapeutics (STOK) United States $0.641B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.636B 0.00
Mineralys Therapeutics (MLYS) United States $0.636B 0.00
Sana Biotechnology (SANA) United States $0.621B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.607B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.604B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
CorMedix Inc (CRMD) United States $0.598B 0.00
IGM Biosciences (IGMS) United States $0.597B 0.00
ChromaDex (CDXC) United States $0.590B 772.00
GRAIL (GRAL) United States $0.588B 0.00
Astria Therapeutics (ATXS) United States $0.586B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.584B 0.00
Olema Pharmaceuticals (OLMA) United States $0.580B 0.00
Third Harmonic Bio (THRD) United States $0.575B 0.00
Annexon (ANNX) United States $0.575B 0.00
Humacyte (HUMA) United States $0.569B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.559B 0.00
Emergent Biosolutions (EBS) United States $0.548B 0.00
Abivax SA (ABVX) France $0.540B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.534B 0.00
PureTech Health (PRTC) United States $0.532B 0.00
Terns Pharmaceuticals (TERN) United States $0.530B 0.00
MeiraGTx Holdings (MGTX) United States $0.529B 0.00
Allogene Therapeutics (ALLO) United States $0.520B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.501B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.500B 0.00
Pharming Group (PHAR) Netherlands $0.499B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.497B 0.00
REGENXBIO (RGNX) United States $0.491B 0.00
Zenas BioPharma (ZBIO) United States $0.481B 0.00
Cartesian Therapeutics (RNAC) United States $0.479B 0.00
Celcuity (CELC) United States $0.475B 0.00
Sangamo Therapeutics (SGMO) United States $0.472B 0.00
Aura Biosciences (AURA) United States $0.465B 0.00
GH Research (GHRS) Ireland $0.465B 0.00
ACELYRIN, INC (SLRN) United States $0.456B 0.00
Foghorn Therapeutics (FHTX) United States $0.444B 0.00
Alumis (ALMS) United States $0.437B 0.00
Prime Medicine (PRME) United States $0.432B 0.00
Tango Therapeutics (TNGX) United States $0.423B 0.00
Alpha Teknova (TKNO) United States $0.398B 0.00
XOMA Royalty (XOMA) United States $0.394B 0.00
Contineum Therapeutics (CTNM) United States $0.384B 0.00
EnGene Holdings (ENGN) Canada $0.382B 0.00
Revance Therapeutics (RVNC) United States $0.379B 0.00
Neurogene (NGNE) United States $0.378B 0.00
Voyager Therapeutics (VYGR) United States $0.375B 9.66
MaxCyte (MXCT) United States $0.374B 0.00
Codexis (CDXS) United States $0.373B 0.00
Northwest Biotherapeutics (NWBO) United States $0.371B 0.00
Fate Therapeutics (FATE) United States $0.361B 0.00
Kodiak Sciences (KOD) United States $0.351B 0.00
Absci (ABSI) United States $0.350B 0.00
Eton Pharmaceuticals (ETON) United States $0.350B 0.00
Jasper Therapeutics (JSPR) United States $0.342B 0.00
Design Therapeutics (DSGN) United States $0.340B 0.00
Kamada (KMDA) Israel $0.339B 21.04
AC Immune (ACIU) Switzerland $0.336B 0.00
Q32 Bio (QTTB) United States $0.328B 0.00
C4 Therapeutics (CCCC) United States $0.321B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.314B 0.00
ITeos Therapeutics (ITOS) United States $0.312B 0.00
Artiva Biotherapeutics (ARTV) United States $0.310B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.300B 0.00
Urogen Pharma (URGN) United States $0.298B 0.00
ATyr Pharma (ATYR) United States $0.296B 0.00
Prima BioMed (IMMP) Australia $0.295B 0.00
Rezolute (RZLT) United States $0.292B 0.00
UniQure (QURE) Netherlands $0.291B 0.00
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Ocugen (OCGN) United States $0.286B 0.00
Tenaya Therapeutics (TNYA) United States $0.283B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Nautilus Biotechnology (NAUT) United States $0.281B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.278B 0.00
Abeona Therapeutics (ABEO) United States $0.278B 0.00
TuHURA Biosciences (HURA) United States $0.277B 0.00
Precigen (PGEN) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.273B 0.00
Biomea Fusion (BMEA) United States $0.262B 0.00
Anika Therapeutics (ANIK) United States $0.260B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.257B 0.00
TScan Therapeutics (TCRX) United States $0.255B 0.00
Alector (ALEC) United States $0.254B 0.00
Kyverna Therapeutics (KYTX) United States $0.249B 0.00
DiaMedica Therapeutics (DMAC) United States $0.242B 0.00
Verastem (VSTM) United States $0.238B 0.00
Applied Therapeutics (APLT) United States $0.236B 0.00
Molecular Partners AG (MOLN) Switzerland $0.235B 0.00
Benitec Biopharma (BNTC) United States $0.234B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.234B 0.00
XBiotech (XBIT) United States $0.232B 0.00
BioStem Technologies (BSEM) $0.231B 20.40
Semper Paratus Acquisition (TVGN) United States $0.229B 0.00
Solid Biosciences (SLDB) United States $0.228B 0.00
Compass Therapeutics (CMPX) United States $0.224B 0.00
Trevi Therapeutics (TRVI) United States $0.221B 0.00
Inhibrx Biosciences (INBX) United States $0.221B 0.00
Sutro Biopharma (STRO) United States $0.219B 0.00
Climb Bio (CLYM) United States $0.217B 0.00
Opthea (OPT) Australia $0.215B 0.00
Checkpoint Therapeutics (CKPT) United States $0.214B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Amarin (AMRN) Ireland $0.208B 0.00
Fulcrum Therapeutics (FULC) United States $0.208B 0.00
2seventy Bio (TSVT) United States $0.206B 0.00
Nkarta (NKTX) United States $0.203B 0.00
Zura Bio (ZURA) United States $0.199B 0.00
Caribou Biosciences (CRBU) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.198B 0.00
Bright Minds Biosciences (DRUG) United States $0.195B 0.00
Ventyx Biosciences (VTYX) United States $0.190B 0.00
Greenwich LifeSciences (GLSI) United States $0.187B 0.00
Cabaletta Bio (CABA) United States $0.187B 0.00
Editas Medicine (EDIT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.184B 0.00
ScPharmaceuticals (SCPH) United States $0.181B 0.00
Instil Bio (TIL) United States $0.176B 0.00
Sagimet Biosciences (SGMT) United States $0.175B 0.00
Inozyme Pharma (INZY) United States $0.174B 0.00
Seres Therapeutics (MCRB) United States $0.167B 0.00
Puma Biotechnology (PBYI) United States $0.166B 7.06
Adherex Technologies (FENC) United States $0.166B 0.00
PepGen (PEPG) United States $0.165B 0.00
Actuate Therapeutics (ACTU) United States $0.159B 0.00
Gossamer Bio (GOSS) United States $0.158B 0.00
Candel Therapeutics (CADL) United States $0.153B 0.00
Black Diamond Therapeutics (BDTX) United States $0.150B 0.00
Seer (SEER) United States $0.146B 0.00
InflaRx (IFRX) Germany $0.145B 0.00
Elutia (ELUT) United States $0.143B 0.00
Cidara Therapeutics (CDTX) United States $0.142B 0.00
Compugen (CGEN) Israel $0.142B 79.50
Coherus BioSciences (CHRS) United States $0.141B 0.00
Repare Therapeutics (RPTX) Canada $0.139B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Adverum Biotechnologies (ADVM) United States $0.138B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.136B 0.00
Skye Bioscience (SKYE) United States $0.136B 0.00
Cardiff Oncology (CRDF) United States $0.133B 0.00
Innate Pharma S.A (IPHA) France $0.125B 0.00
TELA Bio (TELA) United States $0.124B 0.00
Scilex Holding (SCLX) United States $0.123B 0.00
Renovaro (RENB) United States $0.120B 0.00
Alto Neuroscience (ANRO) United States $0.119B 0.00
Monopar Therapeutics (MNPR) United States $0.119B 0.00
Cellectis S.A (CLLS) France $0.117B 0.00
Rani Therapeutics Holdings (RANI) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
INmune Bio (INMB) United States $0.112B 0.00
Immunic (IMUX) United States $0.112B 0.00
Akoya Biosciences (AKYA) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
Adagene (ADAG) China $0.103B 0.00
Generation Bio (GBIO) United States $0.102B 0.00
MediciNova (MNOV) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Vigil Neuroscience (VIGL) United States $0.101B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
Nuvectis Pharma (NVCT) United States $0.097B 0.00
CAMP4 Therapeutics (CAMP) United States $0.097B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
Adicet Bio (ACET) United States $0.093B 0.00
Genelux (GNLX) United States $0.093B 0.00
23andMe Holding (ME) United States $0.093B 0.00
Annovis Bio (ANVS) United States $0.093B 0.00
Allakos (ALLK) United States $0.092B 0.00
Aligos Therapeutics (ALGS) United States $0.092B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.091B 0.00
FibroBiologics (FBLG) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Invivyd (IVVD) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.083B 6.24
Adlai Nortye (ANL) Cayman Islands $0.082B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
BioAtla (BCAB) United States $0.081B 0.00
Ovid Therapeutics (OVID) United States $0.081B 0.00
Agenus (AGEN) United States $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Chimerix (CMRX) United States $0.079B 0.00
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
Invizyne Technologies (IZTC) $0.079B 0.00
Bluebird Bio (BLUE) United States $0.079B 0.00
ALX Oncology Holdings (ALXO) United States $0.078B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
I-Mab (IMAB) China $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.076B 0.00
BeyondSpring (BYSI) United States $0.075B 0.00
DBV Technologies S.A (DBVT) France $0.075B 0.00
ZIVO Bioscience (ZIVO) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Atara Biotherapeutics (ATRA) United States $0.070B 0.00
Passage Bio (PASG) United States $0.070B 0.00
X4 Pharmaceuticals (XFOR) United States $0.067B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Exicure (XCUR) United States $0.064B 0.00
BGM Group (BGM) China $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.062B 16.29
Aileron Therapeutics (ALRN) United States $0.062B 0.00
Boundless Bio (BOLD) United States $0.061B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
IO Biotech (IOBT) Denmark $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Aadi Bioscience (AADI) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Vor Biopharma (VOR) $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
OnKure Therapeutics (OKUR) United States $0.052B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Dyadic (DYAI) United States $0.051B 0.00
AN2 Therapeutics (ANTX) United States $0.050B 0.00
Omega Therapeutics (OMGA) United States $0.049B 0.00
Rallybio (RLYB) United States $0.049B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Affimed (AFMD) Germany $0.046B 0.00
Celularity (CELU) United States $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Rapt Therapeutics (RAPT) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Intensity Therapeutics (INTS) United States $0.041B 0.00
Alpha Cognition (ACOG) Canada $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Beyond Air (XAIR) United States $0.037B 0.00
Curis (CRIS) United States $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Grace Therapeutics (GRCE) Canada $0.034B 0.00
NextCure (NXTC) United States $0.033B 0.00
Forte Biosciences (FBRX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Longeveron (LGVN) United States $0.030B 0.00
HOOKIPA Pharma (HOOK) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.030B 0.00
Medicus Pharma (MDCX) $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Chemomab Therapeutics (CMMB) Israel $0.026B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
LakeShore Biopharma (LSB) China $0.026B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
GeoVax Labs (GOVX) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
Pulmatrix (PULM) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
IN8bio (INAB) United States $0.022B 0.00
Abpro Holdings (ABP) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
UNITY Biotechnology (UBX) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Gelteq (GELS) Australia $0.019B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
Tenax Therapeutics (TENX) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
Cognition Therapeutics (CGTX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
NKGen Biotech (NKGN) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Evaxion Biotech (EVAX) Denmark $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Quantum Biopharma (QNTM) Canada $0.009B 0.00
Biora Therapeutics (BIOR) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Onconetix (ONCO) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
NAYA Biosciences (NAYA) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Aptose Biosciences (APTO) Canada $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00